Pages that link to "Q38074251"
Jump to navigation
Jump to search
The following pages link to Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review (Q38074251):
Displaying 50 items.
- Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function (Q26795398) (← links)
- Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats (Q28548577) (← links)
- The chronic kalaemia conundrum (Q28647234) (← links)
- Updates in hyperkalemia: Outcomes and therapeutic strategies (Q30245585) (← links)
- Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. (Q30451024) (← links)
- Advances in treatment of hyperkalemia in chronic kidney disease (Q34491934) (← links)
- Emerging therapies for the management of chronic hyperkalemia in the ambulatory care setting (Q34507073) (← links)
- A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient (Q35921862) (← links)
- Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia. (Q36003502) (← links)
- Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review (Q36009244) (← links)
- Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients (Q36318268) (← links)
- Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia (Q36369282) (← links)
- Potassium-Binding Agents for the Clinical Management of Hyperkalemia (Q36425315) (← links)
- Potassium and Its Discontents: New Insight, New Treatments (Q36746113) (← links)
- Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial (Q37275785) (← links)
- Total colectomy for colon perforation after kayexalate administration: a case report and literature review of a rare complication (Q37321453) (← links)
- An electronic alert to decrease Kayexalate ordering. (Q37420987) (← links)
- Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review (Q37722892) (← links)
- Histopathological changes in the gastrointestinal tract due to drugs: an update for the surgical pathologist (part I of II). (Q38136048) (← links)
- Message in a bottle: decoding medication injury patterns in the gastrointestinal tract (Q38230008) (← links)
- Management of hyperkalaemia in chronic kidney disease (Q38249892) (← links)
- Iatrogenic pathology of the intestines. (Q38339456) (← links)
- Potential New Agents for the Management of Hyperkalemia (Q38544101) (← links)
- Treatment of Hyperkalemia in Heart Failure (Q38705827) (← links)
- Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia (Q38783092) (← links)
- Global cardiovascular protection in chronic kidney disease (Q38800239) (← links)
- Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate (Q38842296) (← links)
- Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia. (Q38890685) (← links)
- Managing Hyperkalemia: Stepping Into a New Frontier (Q38949822) (← links)
- Resin-Induced Colonic Pseudotumor: Rare Complication from Chronic Use of Potassium Binders in a Hemodialysis Patient (Q38961797) (← links)
- Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia (Q38999653) (← links)
- Medication-associated gastrointestinal tract injury (Q39108620) (← links)
- Runner's new diet, his collapse, and his ECG: when a rapid ECG diagnosis can save the day (Q40344401) (← links)
- Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia (Q40753618) (← links)
- Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate (Q41355707) (← links)
- Cation Exchange Resins and colonic perforation. What surgeons need to know (Q42006308) (← links)
- Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis (Q42386495) (← links)
- Taking a Second Look at Kayexalate (Q42564233) (← links)
- ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). (Q46195549) (← links)
- Revisiting RAAS blockade in CKD with newer potassium-binding drugs (Q47669329) (← links)
- Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk (Q47832629) (← links)
- Treatment of Severe Hyperkalemia: Confronting 4 Fallacies (Q49395610) (← links)
- Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice (Q50051683) (← links)
- Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease (Q50063221) (← links)
- The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy (Q50101692) (← links)
- Refractory hypoxemia due to sodium polystyrene sulfonate (kayexalate) aspiration. (Q51710160) (← links)
- Hyperkalemia in the Hypertensive Patient. (Q52680286) (← links)
- Unusual ileus due to calcium polystyrene sulfonate. (Q52983613) (← links)
- Colitis induced by sodium polystyrene sulfonate in sorbitol: A report of six cases. (Q53132577) (← links)
- Sodium polystyrene sulfonate crystals in the gastric wall of a patient with upper gastrointestinal bleeding and gastric perforation: an incidental finding or a pathogenic factor? (Q55483590) (← links)